Treatment Strategy for Ultra-High-Risk Multiple Myelomas with Chromosomal Aberrations Considering Minimal Residual Disease Status and Bone Marrow Microenvironment

Suzuki, K; Yano, S

Suzuki, K (通讯作者)，Jikei Univ, Sch Med, Dept Internal Med, Div Clin Oncol & Hematol, 3-19-18 Nishi-Shimbashi, Minato-ku, Tokyo 1050003, Japan.

CANCERS, 2023; 15 (9):

Abstract

Proteasome inhibitors, immunomodulatory drugs, anti-CD38 monoclonal antibodies (triple class drugs), and autologous stem cell transplantation (ASCT) a......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索